Press release
MedTech CMO Market Size, Trends and Industry Analysis Forecast to 2029
The global MedTech CMO market is growing at a healthy rate of 11% due to increased outsourcing by OEMs and higher growth rates in segments like Drug delivery and MIS (Minimally Invasive Surgery). Additionally, the growing burden of chronic diseases, the rising demand for cost-effective medical devices and the increasing complexity of regulatory requirements, further drives the MedTech CMO market.The MedTech CMO (Contract Manufacturing Organization) market involves outsourcing the manufacturing of medical devices and equipment to specialized third-party organizations.
Explore market trends, size, share and growth report - request a sample copy: https://meditechinsights.com/medtech-cmo-market/request-sample/
The Strategic Benefits Fueling MedTech Companies' Shift to CMO Services
The decision to engage Contract Manufacturing Organization (CMO) services is primarily driven by the need to reduce costs and improve operational efficiency. CMOs provide substantial cost advantages, enabling medical device companies to reduce capital expenditure on manufacturing infrastructure and labour. Additionally, the increasing complexity of regulatory requirements makes it challenging for companies to maintain compliance independently. CMOs, with their specialized expertise and established compliance frameworks, ensure adherence to global standards, mitigating regulatory risks. The flexibility and scalability offered by CMOs enable companies to respond swiftly to market demands, scale production, and bring new products to market faster. This strategic partnership allows companies to focus on their core competencies, such as research, development, and marketing, fostering innovation and competitive advantage.
Key Trends Shaping the MedTech CMO Market
Several key trends are shaping the MedTech CMO market, reflecting advancements in technology and changing market dynamics. A significant trend is the shift towards offering end-to-end services, from design and development to manufacturing and supply chain management. Sophisticated CMOs focus on areas like miniaturization of batteries, data connectivity, and IoT, which are highly valued by OEMs. Their deep knowledge of end markets enables them to spot emerging trends and technologies, differentiating themselves from competitors and providing superior solutions. The integration of advanced manufacturing is revolutionizing production processes, leading to higher precision, reduced time-to-market, and cost efficiencies. Additionally, the growing emphasis on personalized medicine is driving demand for customized and patient-specific medical devices, prompting CMOs to invest in technologies that support this trend. Sustainability and green manufacturing practices are becoming increasingly important, with CMOs adopting environmentally friendly materials and processes to meet regulatory and consumer expectations.
Leveraging CMOs for Superior Medical Device Solutions
The rise of telehealth and remote monitoring devices is expanding the scope of CMO services, necessitating the production of more connected and portable medical devices. Strategic partnerships and collaborations between MedTech companies and CMOs are also on the rise, leveraging shared expertise and resources to co-develop innovative solutions. Partnering with a Contract Manufacturing Organization (CMO) for medical device production offers MedTech companies numerous strategic advantages. CMOs provide access to advanced manufacturing technologies, such as 3D printing and automation, which enhance product quality and reduce time-to-market. Their specialized expertise in regulatory compliance helps navigate complex global standards more efficiently, ensuring products meet stringent quality requirements. CMOs also offer scalability and flexibility, allowing companies to adapt to market demands without the need for significant capital investment in manufacturing infrastructure.
Post-Covid-19 trends include an increased focus on the resiliency of supply chains, increased outsourcing and consolidation of suppliers
Prior to the pandemic, increasing sophistication by CMOs has made large OEMs more comfortable to outsource complete products- this trend is likely to continue. However, OEMs are now increasingly looking at the resiliency of their suppliers, and their supply chains and potentially looking to consolidate the supplier base to build deeper partnerships with a few select suppliers.
"Undoubtedly, COVID-19 challenged both the OEMs and CDMOs. However, this impact is likely to be short-term and the fundamental trajectory of both the industries is expected to remain on track with long-term gains"- Exec VP, CFO, Leading U.S MedTech CMO
Key Challenges / Restraints
The MedTech CMO market faces several restraints, including stringent regulatory requirements and the high cost of compliance, which can limit the entry of new players and increase operational costs for existing CMOs. Additionally, concerns over intellectual property protection and quality control can hinder the willingness of MedTech companies to outsource critical manufacturing processes. Lastly, the reliance on CMOs can lead to supply chain vulnerabilities, particularly in times of global disruptions or geopolitical tensions.
Regional Insights in the MedTech CMO Market
The MedTech CMO market is driven by distinct factors across various regions. In North America, the market is propelled by a robust healthcare infrastructure, significant investment in research and development, and the presence of leading MedTech companies. Europe's growth is fueled by stringent regulatory standards and a strong emphasis on quality, which increases the demand for specialized CMO services. The Asia-Pacific region benefits from cost advantages, a burgeoning healthcare sector, and rising medical device production. Additionally, emerging markets in Latin America and the Middle East are experiencing growth due to improving healthcare facilities and increasing demand for advanced medical devices.
MedTech CMO Market Segmentation Insights by Product & Services
Key product and service segments in the MedTech CMO market include design, manufacturing, sterilization, and packaging. Design services focus on developing innovative medical devices, manufacturing ensures high-quality production, sterilization maintains safety, and packaging provides secure transport and storage. Among these, manufacturing holds the dominant share, driven by the increasing volume and complexity of medical devices requiring advanced production techniques.
MedTech CMO Market Segmentation Insights by End-Market
In the MedTech CMO market, Drug Delivery Devices, Orthopedics, and Minimally Invasive Surgery (MIS) emerge as dominant segments, each pivotal in driving innovation and setting high standards for manufacturing precision. Drug Delivery Devices ensure precise therapeutics administration, Orthopedics advances mobility through prosthetics and implants, while MIS leads surgical innovation with sophisticated tools. These segments collectively propel the industry forward, shaping the future of healthcare delivery with their advanced technologies and commitment to enhancing patient outcomes worldwide.
Competitive Landscape Analysis
Some of the key players having a strong foothold in the global MedTech CMO market and offering a wide range of products & services include Jabil, Flex Corporation, Integer Corporation, Tecomet, TE Connectivity, Gerresheimer, Integer Corporation, Nipro Corporation, West Pharmaceuticals Services, and Sanmina Corporation among others.
Request for TOC and Competitive Analysis: https://meditechinsights.com/medtech-cmo-market/
Organic and Inorganic Growth Strategies Adopted by the Leading Market Players to Establish Their Foothold in the Global MedTech CMO Market
Leading players operating in the global market are adopting both organic and inorganic growth strategies such as launching new services, acquiring related firms, and entering into collaborations to garner a higher market share.
In November 2023, Jabil Inc. announced the acquisition of Renotrix, an innovative provider in the reclamation and refurbishment of electronic components, the acquisition adds to Jabil's economy services like medical device reprocessing, and recycled packaging
In June 2023, four prominent medical device manufacturing companies-EOS, Tecomet, Orthopaedic Innovation Centre (OIC), and Precision ADM-announced a collaborative partnership to provide an end-to-end solution for medical device additive manufacturing (AM), encompassing front-end engineering and design, 510k approval pathways, device and machine validation, pre-clinical testing, and commercialization
In January 2023, Integer announced the acquisition of Pulse Technologies, the acquisition aims at focus on complex micromachining medical device components for high-growth structural heart
The Global MedTech CMO Market is expected to gain further momentum in the upcoming years due to the growing demand for medical devices, increasing preference for outsourcing services by OEMs, technological advancements, stringent regulatory policies and aggressive organic and inorganic growth strategies followed by the key market players.
Key Strategic Questions Addressed
What is the market size & forecast for the Global MedTech CMO Market?
What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the Global MedTech CMO Market?
How has COVID-19 impacted the Global MedTech CMO Market?
What are the major growth drivers, restraints/challenges impacting the market?
What are the opportunities prevailing in the market?
What is the investment landscape?
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
Who are the major players operating in the market? What is the competitive positioning of key players?
Who are the new players entering the market?
What are the key strategies adopted by players?
Find more related report:
Telehealth & Telemedicine Market: https://meditechinsights.com/telehealth-telemedicine-market/
IVD Contract Manufacturing Services Market: https://meditechinsights.com/ivd-contract-manufacturing-services-market/
Advanced Drug Delivery CDMO Market: https://meditechinsights.com/advanced-drug-delivery-cdmo-market/
Contact:
Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MedTech CMO Market Size, Trends and Industry Analysis Forecast to 2029 here
News-ID: 3938832 • Views: …
More Releases from Medi-Tech Insights

Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…

Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market.
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.…

Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…

High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
More Releases for CMO
Healthcare Cmo Market Size Analysis by Application, Type, and Region: Forecast t …
USA, New Jersey- According to Market Research Intellect, the global Healthcare Cmo market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The healthcare contract manufacturing organization (CMO) market is witnessing steady expansion due to increasing demand for outsourced pharmaceutical and medical device production. Rising healthcare costs…
New Fractional CMO Agency Offers Fractional CMO Services to Businesses of All Si …
Modern CMO, a new fractional CMO agency, has officially launched to offer businesses of all sizes access to expert-level marketing strategies and a team of experienced CMOs to lead their marketing initiatives.
Modern CMO's fractional CMO services provide businesses with access to the same level of expertise as a full-time CMO, without the costly overhead expenses. This means that businesses can tap into Modern CMO's pool of highly skilled marketing professionals…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…